Leni George
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Leni George has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Susanne Pulimood
Professor, Department of Dermatology, Christian Medical College, India
3 shared publicationsMeera Thomas
Department of Dermatology, Christian Medical College, Vellore, Tamil Nadu, India
2 shared publicationsA. Srivastava
Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India
1 shared publication- Anu Anna George
Department of Dermatology, Christian Medical College, Vellore, India
1 shared publication Asish Gupta
Department of Plastic Surgery, Christian Medical College, Vellore, Tamilnadu, India
1 shared publicationB. George
Department of Haematology, Christian Medical College, Vellore, Tamil Nadu, India
1 shared publication
Latest Publications
- Open Access
- 27 April 2026
- Published by Brieflands in International Journal of Endocrinology and Metabolism
- Vol. 24 (3) , e166723
Discordantly Low HbA1c in Patients Receiving Dapsone: Prevalence and Associations with Hemolysis and Methemoglobinemia
Background: Glycosylated hemoglobin (HbA1c) is widely used for the diagnosis and long-term monitoring of diabetes mellitus (DM). However, its accuracy may be compromised by conditions and medications that alter erythrocyte lifespan or hemoglobin structure. Dapsone, commonly used in the treatment of Hansen’s disease, has been reported to cause spuriously low HbA1c values, but systematic data on its prevalence and underlying mechanisms remain limited. Objectives: The objectives of this study were to (1) determine the prevalence of discordantly low HbA1c levels in patients receiving dapsone therapy, including individuals with and without DM; (2) explore associations between discordant HbA1c and markers of hemolysis and methemoglobinemia; and (3) compare measured HbA1c values obtained by high-performance liquid chromatography (HPLC) with expected HbA1c values derived from fructosamine using the glycosyl gap. Methods: This retrospective cross-sectional study included 30 patients receiving oral dapsone for Hansen’s disease and 10 healthy controls. HbA1c was measured using ion-exchange HPLC and compared with expected HbA1c values calculated from serum fructosamine. Parameters related to hemolysis and methemoglobinemia were assessed. Discordant HbA1c was defined by a negative glycosyl gap. Subgroup analyses were exploratory. Results: Among patients receiving dapsone, 16 had DM and 14 were normoglycemic. Discordantly low HbA1c was observed in 27 of 30 patients (90%), including 15 of 16 patients with DM and 12 of 14 without diabetes. Markers of hemolysis and methemoglobinemia showed trends consistent with biological plausibility but did not demonstrate statistically significant differences sufficient to establish causality. Conclusions: A high prevalence of discordantly low HbA1c was observed among patients receiving dapsone therapy, highlighting an important clinical pitfall in the interpretation of HbA1c. While hemolysis and methemoglobinemia remain biologically plausible contributors, these findings should be considered hypothesis-generating. Clinicians should exercise caution when interpreting HbA1c in patients treated with dapsone and consider alternative glycemic markers such as fructosamine.
- 27 April 2026
- Published by Brieflands in International Journal of Endocrinology and Metabolism
- Vol. 24 (3) , e166723
Open AccessDiscordantly Low HbA1c in Patients Receiving Dapsone: Prevalence and Associations with Hemolysis and Methemoglobinemia
Background: Glycosylated hemoglobin (HbA1c) is widely used for the diagnosis and long-term monitoring of diabetes mellitus (DM). However, its accuracy may be compromised by conditions and medications that alter erythrocyte lifespan or hemoglobin structure. Dapsone, commonly used in the treatment of Hansen’s disease, has been reported to cause spuriously low HbA1c values, but systematic data on its prevalence and underlying mechanisms remain limited. Objectives: The objectives of this study were to (1) determine the prevalence of discordantly low HbA1c levels in patients receiving dapsone therapy, including individuals with and without DM; (2) explore associations between discordant HbA1c and markers of hemolysis and methemoglobinemia; and (3) compare measured HbA1c values obtained by high-performance liquid chromatography (HPLC) with expected HbA1c values derived from fructosamine using the glycosyl gap. Methods: This retrospective cross-sectional study included 30 patients receiving oral dapsone for Hansen’s disease and 10 healthy controls. HbA1c was measured using ion-exchange HPLC and compared with expected HbA1c values calculated from serum fructosamine. Parameters related to hemolysis and methemoglobinemia were assessed. Discordant HbA1c was defined by a negative glycosyl gap. Subgroup analyses were exploratory. Results: Among patients receiving dapsone, 16 had DM and 14 were normoglycemic. Discordantly low HbA1c was observed in 27 of 30 patients (90%), including 15 of 16 patients with DM and 12 of 14 without diabetes. Markers of hemolysis and methemoglobinemia showed trends consistent with biological plausibility but did not demonstrate statistically significant differences sufficient to establish causality. Conclusions: A high prevalence of discordantly low HbA1c was observed among patients receiving dapsone therapy, highlighting an important clinical pitfall in the interpretation of HbA1c. While hemolysis and methemoglobinemia remain biologically plausible contributors, these findings should be considered hypothesis-generating. Clinicians should exercise caution when interpreting HbA1c in patients treated with dapsone and consider alternative glycemic markers such as fructosamine.
- 7 June 2018
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 44 (2) , 161-168
Utility of tissue elafin as an immunohistochemical marker for diagnosis of acute skin graft-versus-host disease: a pilot study
Background The skin is the most common organ involved in acute graft‐versus‐host disease (GvHD). Because histopathology has limited utility in ruling out clinical mimics of acute skin GvHD, more accurate diagnostic techniques are required. Aim To evaluate the utility of elafin expression in skin by immunohistochemistry (IHC) for accurate diagnosis of acute skin GvHD. Methods Consecutive allogeneic haematopoietic stem cell transplant (HSCT) recipients during a 6‐month period who developed rash within the first 100 days post‐transplant were recruited. Skin biopsies were taken on the day the rash developed. IHC for epidermal elafin was performed and interpreted by a pathologist blinded to the histopathological diagnosis. Staining of ≥ 50% of epidermis was considered positive. Final diagnosis of the rash was assigned using clinical features supported by histopathology. The accuracy of elafin IHC in predicting the final diagnosis of acute GvHD was evaluated. Results In total, 23 patients (20 male, 3 female; median age 16 years, range 3–53 years) with 27 episodes of skin rash were recruited. Skin rash post‐HSCT occurred at a median of 20 days (range 5–45 days). A diagnosis of GvHD was made in 16 episodes (59.26%) while the remaining 11 episodes (40.74%) were judged to be non‐GvHD rash. Elafin IHC was positive in all patients with GvHD. Of the 11 episodes of non‐GvHD rash, elafin was negative in 8. Thus, the sensitivity and specificity of elafin IHC for predicting acute skin GvHD was 100% and 75%, respectively. Conclusion Tissue elafin is a useful immunohistochemical marker for acute skin GvHD. However, larger studies are needed to validate these results.
- 7 June 2018
- Published by Oxford University Press (OUP) in Clinical and Experimental Dermatology
- Vol. 44 (2) , 161-168
Utility of tissue elafin as an immunohistochemical marker for diagnosis of acute skin graft-versus-host disease: a pilot study
Background The skin is the most common organ involved in acute graft‐versus‐host disease (GvHD). Because histopathology has limited utility in ruling out clinical mimics of acute skin GvHD, more accurate diagnostic techniques are required. Aim To evaluate the utility of elafin expression in skin by immunohistochemistry (IHC) for accurate diagnosis of acute skin GvHD. Methods Consecutive allogeneic haematopoietic stem cell transplant (HSCT) recipients during a 6‐month period who developed rash within the first 100 days post‐transplant were recruited. Skin biopsies were taken on the day the rash developed. IHC for epidermal elafin was performed and interpreted by a pathologist blinded to the histopathological diagnosis. Staining of ≥ 50% of epidermis was considered positive. Final diagnosis of the rash was assigned using clinical features supported by histopathology. The accuracy of elafin IHC in predicting the final diagnosis of acute GvHD was evaluated. Results In total, 23 patients (20 male, 3 female; median age 16 years, range 3–53 years) with 27 episodes of skin rash were recruited. Skin rash post‐HSCT occurred at a median of 20 days (range 5–45 days). A diagnosis of GvHD was made in 16 episodes (59.26%) while the remaining 11 episodes (40.74%) were judged to be non‐GvHD rash. Elafin IHC was positive in all patients with GvHD. Of the 11 episodes of non‐GvHD rash, elafin was negative in 8. Thus, the sensitivity and specificity of elafin IHC for predicting acute skin GvHD was 100% and 75%, respectively. Conclusion Tissue elafin is a useful immunohistochemical marker for acute skin GvHD. However, larger studies are needed to validate these results.
- Open Access
- 1 January 2018
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 9 (1) , 44-46
Acquired cutis laxa associated with light and heavy chain deposition disease
Avy chain (LHCDD) deposition disease. MIDD predominantly involves the kidney. Skin is the next common organ to be affected by HCDD, which presents as ACL. We report the case of a 40-year-old male who presented with ACL associated with LHCDD. The clinical features of ACL in the present case appeared prior to the development of clinical features related to LHCDD....
- 1 January 2018
- Published by Medknow in Indian Dermatology Online Journal
- Vol. 9 (1) , 44-46
Open AccessAcquired cutis laxa associated with light and heavy chain deposition disease
Avy chain (LHCDD) deposition disease. MIDD predominantly involves the kidney. Skin is the next common organ to be affected by HCDD, which presents as ACL. We report the case of a 40-year-old male who presented with ACL associated with LHCDD. The clinical features of ACL in the present case appeared prior to the development of clinical features related to LHCDD....
- 24 June 2013
- Published by SAGE Publications in Tropical Doctor
- Vol. 43 (3) , 110-112
Novel multidrug therapy for disseminated rhinosporidiosis, refractory to dapsone – case report
Rhinosporidiosis is a chronic granulomatous disorder, caused by Rhinosporidium seeberi endemic in India and Sri Lanka. The most common sites are the nasal mucosa and the nasopharynx and cutaneous lesions usually occur as a part of disseminated rhinosporidiosis. Dapsone has been frequently used in treating disseminated disease in immunocompetent individuals. Here we report a case of disseminated rhinosporidiosis in an immunocompromised individual on antiretroviral drugs, non-responsive to Dapsone and therefore treated with a multidrug therapy of Cycloserine, Dapsone and Ketoconazole with good response.
- 24 June 2013
- Published by SAGE Publications in Tropical Doctor
- Vol. 43 (3) , 110-112
Novel multidrug therapy for disseminated rhinosporidiosis, refractory to dapsone – case report
Rhinosporidiosis is a chronic granulomatous disorder, caused by Rhinosporidium seeberi endemic in India and Sri Lanka. The most common sites are the nasal mucosa and the nasopharynx and cutaneous lesions usually occur as a part of disseminated rhinosporidiosis. Dapsone has been frequently used in treating disseminated disease in immunocompetent individuals. Here we report a case of disseminated rhinosporidiosis in an immunocompromised individual on antiretroviral drugs, non-responsive to Dapsone and therefore treated with a multidrug therapy of Cycloserine, Dapsone and Ketoconazole with good response.
- Open Access
- 1 January 2009
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 75 (3) , 255-61
Skin lesions in renal transplant recipients: A single center analysis
The chronic use of immunosuppressants in renal transplant recipients (RTRs) predisposes them to a variety of skin manifestations. Studies on skin lesions in RTRs from India have been limited. To study the prevalence and clinical spectrum of skin diseases in RTR in patients attending the Nephrology clinic of a tertiary care hospital in South India. Between October 2002 and June 2003, 365 RTRs were evaluated for skin lesions, including 280 examined after renal transplant (group A) and 85 examined once before and then monthly after transplant for a period of 6 months (group B). A total of 1163 skin lesions were examined in 346 RTRs (94.7%) including lesions of aesthetic interest (LAI) [62.3%] followed by infections [27.3%]. All LAI were drug-related manifestations, making it the most common skin lesion, while fungal (58.7%) and viral (29.3%) infections constituted majority of lesions caused by infection. Lesions related to neoplasms were relatively uncommon (2.1%) and all lesions were benign. Miscellaneous lesions constituted 8.3% of skin lesions, which included vaccine-induced necrobiotic granulomas at the site of Hepatitis B vaccination and acquired perforating dermatoses. Skin lesions among RTRs from India consist predominantly of drug-related LAI and infections and are different from the West in view of the paucity of neoplastic lesions.
- 1 January 2009
- Published by Scientific Scholar in Indian Journal of Dermatology, Venereology and Leprology
- Vol. 75 (3) , 255-61
Open AccessSkin lesions in renal transplant recipients: A single center analysis
The chronic use of immunosuppressants in renal transplant recipients (RTRs) predisposes them to a variety of skin manifestations. Studies on skin lesions in RTRs from India have been limited. To study the prevalence and clinical spectrum of skin diseases in RTR in patients attending the Nephrology clinic of a tertiary care hospital in South India. Between October 2002 and June 2003, 365 RTRs were evaluated for skin lesions, including 280 examined after renal transplant (group A) and 85 examined once before and then monthly after transplant for a period of 6 months (group B). A total of 1163 skin lesions were examined in 346 RTRs (94.7%) including lesions of aesthetic interest (LAI) [62.3%] followed by infections [27.3%]. All LAI were drug-related manifestations, making it the most common skin lesion, while fungal (58.7%) and viral (29.3%) infections constituted majority of lesions caused by infection. Lesions related to neoplasms were relatively uncommon (2.1%) and all lesions were benign. Miscellaneous lesions constituted 8.3% of skin lesions, which included vaccine-induced necrobiotic granulomas at the site of Hepatitis B vaccination and acquired perforating dermatoses. Skin lesions among RTRs from India consist predominantly of drug-related LAI and infections and are different from the West in view of the paucity of neoplastic lesions.
- 1 January 2008
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 19 (1) , 61-63
Frontal rhytidectomy as surgical treatment for pachydermoperiostosis: A case report
The thickened folded skin of Touraine‐Solente‐Golé syndrome can result in cosmetic and functional deformities. The treatment of pachydermoperiostosis is usually centered around improving the cosmetic appearance through plastic surgery. We describe the case of a 27‐year‐old male who had pachydermoperiostosis with a leonine facies that was managed with frontal rhytidectomy. A greatly improved cosmetic appearance was achieved with this procedure.
- 1 January 2008
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 19 (1) , 61-63
Frontal rhytidectomy as surgical treatment for pachydermoperiostosis: A case report
The thickened folded skin of Touraine‐Solente‐Golé syndrome can result in cosmetic and functional deformities. The treatment of pachydermoperiostosis is usually centered around improving the cosmetic appearance through plastic surgery. We describe the case of a 27‐year‐old male who had pachydermoperiostosis with a leonine facies that was managed with frontal rhytidectomy. A greatly improved cosmetic appearance was achieved with this procedure.